以“火郁发之”论治EGFRIs相关皮疹经验撷菁

Experience of treating EGFRIs relevant rash with “divergencing the stagnant fire”

随着表皮生长因子受体抑制剂(EGFRIs)广泛应用于肿瘤治疗,其不良反应也愈益显著,其中药物相关性皮疹最为明显,也最难以耐受。目前西医对症治疗对其效果欠佳,故而探索EGFRIs相关皮疹的有效治疗方法极为迫切。导师叶小卫教授据多年临证经验,以"火郁发之"理论治疗EGFRIs相关皮疹每获良效,现将吾师之治疗经验总结如下,以飨同道。

With the epidermal growth factor receptor inhibitions widely used in tumor therapy,it’s side effects are also increasingly obvious.The most obvious is the drug-related rash,and also the most difficult to tolerate.At present,the western medicine symptomatic treatment has poor results,so the exploration of EGFRIs related rash effective treatment is extremely urgent.According to years of clinical experience,my instructor professor YE Xiaowei,use the“divergencing the stagnant fire”theory to treat the EGFRIs related rash has reward good effect,now Professor Ye’s treatment experience has been summarized as follows to share to fellow.